Teva share price at 6-year high after trial results

Teva CEO Richard Francis credit: Teva Spokesperson
Teva CEO Richard Francis credit: Teva Spokesperson

The Israeli pharmaceutical company's market cap gained $5 billion in one Wall Street session boosting Israeli pension funds by hundreds of millions of dollars.

The market cap of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA rose by $5 billion yesterday, after the share price jumped 26%. The sharp rise, making Teva once again the most valuable Israel company on Wall Street, with a market cap of $23.7 billion - a six year high. The share price opened 1.34% higher on the NYSE today, giving a market cap of $24 billion.

The dramatic rise is another peak in Teva's recovery over the past year and rewards investors after a long period of disappointment. Over the past year, Teva has doubled its market value and is now trading at a value three times higher than the low it hit in 2020, a low that almost recurred in the summer of 2022.

The latest leap in share price follows publication of successful Phase 2b trial results for Dukavitug, which it is developing together with Sanofi, for the treatment of ulcerative colitis and Crohn's disease, the two most common forms of inflammatory bowel diseases According to Teva's announcement the primary endpoint results in ulcerative colitis and Crohn's disease for high dose represent the highest achieved with any TL1A monoclonal antibody. Teva head of global R&D and chief medical officer Eric Hughes said that the results from the study have exceeded expectations.

The biggest beneficiaries 'on paper' from the jump in Teva's share price include several Israeli institutional bodies. There is currently one party-at-interest in Teva - the Fidelity Management & Research (FMR), which holds a 5.5% stake, the value of which rose $274 million yesterday to $1.3 billion. According to data from SmartBull, which has developed systems for analyzing the capital market, Israeli institutional investors with significant stakes in Teva include Menora Mivtachim with shares worth $544 million, Clal Insurance with shares worth $491 million, and Migdal with shares worth $480 million. Clal said, "Members enjoyed a profit of NIS 530 million from the rise in the share price following publication of the trial results."

Published by Globes, Israel business news - en.globes.co.il - on December 18, 2024

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024

Teva CEO Richard Francis credit: Teva Spokesperson
Teva CEO Richard Francis credit: Teva Spokesperson
Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef OECD sees recovery in growth but high inflation

The OECD Israel Economic Survey 2025 recommends that the Israeli government take several restraining measures, in order to exit the economic storm created by the war.

Dano Ben-Hur credit: Dror Sithakol Statisticians contradict BoI on impact of housing finance deals

The Central Bureau of Statistics insists the impact of 20/80 buy now pay later financing deals on the real estate market and housing prices is minimal.

Governor of the Bank of Israel Amir Yaron  credit: Government Press Office Debt fears top Bank of Israel's concerns

Most unusually, Governor of the Bank of Israel Amir Yaron's press conference last week did not focus on inflation and the impending interest rate decision.

US President Donald Trump  credit: Reuters/Leah Millis Israel moves to avoid Trump's tariffs axe

Minister of Finance Bezalel Smotrich has signed an order canceling all tariffs on imports from the US. The impact will mostly be on agricultural produce.

Forbes Rich List credit: Shutterstock Maslowski Marcin Wiz founders ranked in Forbes 2025 Rich List

There are a few dozen Israelis listed in the 2025 Forbes Real-Time Billionaires List including Wiz founders Assaf Rappaport, Yinon Costica, Roy Reznik and Ami Luttwak.

SatixFy CEO Nir Barkan credit: Ariel Barkan Canada's MDA Space to buy Israeli satcom co SatixFy

MDA Space will pay $269 million for the Israeli company, including taking on a $76 million debt and a 75% premium on SatixFy's closing price on Nasdaq yesterday.

Raising dollars credit: Shutterstock Israeli startups raised over $1b in March

Israeli privately-held tech companies have raised $2.1 billion in the first three months of 2025, according to IVC-LeumiTech, up 24% from the corresponding quarter of 2024.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018